Pharmacotherapy for Alcohol Use Disorder: A Comprehensive Review of Current Treatments and Future Directions
Medical Research Archives · 27.02.2025 · 13 (2)
DOI: 10.18103/mra.v13i2.6328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 27.02.2025. Verfasst von J. Andrew Legan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Over the past decade, research into pharmacotherapy for alcohol use disorder (AUD) has significantly expanded. Three medications—naltrexone (including its extended-release (XR formulation, Vivitrol®), acamprosate, and disulfiram—are Food and Drug Administration (FDA) and European Medicines Agency (EMA) approved for alcohol use disorder treatment. In some European regions, baclofen, nalmefene, and sodium oxybate are also approved for alcohol use disorder treatment. Despite their widespread use, variability in clinical outcomes underscores the need for more tailored treatment strategies. Several emerging medications show promise for treating alcohol use disorder. Among the numerous neurotransmitter systems identified for novel drug development, the most promising compounds modulate the functions of opioids, glutamate (with or without gamma-aminobutyric acid), and serotonin. Other potential therapeutic agents target systems involved in sleep, appetite, stress response, and neuroplasticity. While more research is needed to confirm the efficacy of these agents in larger clinical trials, they represent an exciting new avenue for alcohol use disorder treatment. In summary, while established treatments for alcohol use disorder remain essential, there is a growing need for more personalized approaches. These strategies should address not only alcohol-related reward mechanisms but also symptoms of withdrawal, cravings, depression, cognitive processing, and sleep disturbances. The exploration of new pharmacotherapies offers hope for improved outcomes, with treatment tailored to each individual’s unique needs.
Zitieren
APA
Legan, J. A., Gentry, J., Shugoll, J., Zhong, Q., & Ait-Daoud,, N. (2025). Pharmacotherapy for Alcohol Use Disorder: A Comprehensive Review of Current Treatments and Future Directions. Medical Research Archives, 13(2). https://doi.org/10.18103/mra.v13i2.6328
Vancouver
Legan JA, Gentry J, Shugoll J, Zhong Q, Ait-Daoud, N. Pharmacotherapy for Alcohol Use Disorder: A Comprehensive Review of Current Treatments and Future Directions. Medical Research Archives. 2025;13(2). doi:10.18103/mra.v13i2.6328
BibTeX
@article{Legan2025,
author = {Legan, J. Andrew and Gentry, Jamie and Shugoll, Jason and Zhong, Quincy and Ait-Daoud,, Nassima},
title = {Pharmacotherapy for Alcohol Use Disorder: A Comprehensive Review of Current Treatments and Future Directions},
journal = {Medical Research Archives},
year = {2025},
volume = {13},
number = {2},
doi = {10.18103/mra.v13i2.6328}
}
EUVIMED